핵의학

본문글자크기
  • [JAMA Psychiatry.] Inflammation in the Neurocircuitry of Obsessive-Compulsive Disorder.

    Campbell Family Mental Health Research Institute,University of Toronto, Sunnybrook Health Sciences Centre / Romina Mizrahi*, Margaret Anne Richter*, Alan Kahn*, Sylvain Houle*, Lakshmi Ravindran*

  • 출처
    JAMA Psychiatry.
  • 등재일
    2017 Aug 1
  • 저널이슈번호
    74(8):833-840. doi: 10.1001/jamapsychiatry.2017.1567.
  • 내용

    바로가기  >

    Abstract


    IMPORTANCE:

    For a small percentage of obsessive-compulsive disorder (OCD) cases exhibiting additional neuropsychiatric symptoms, it was proposed that neuroinflammation occurs in the basal ganglia as an autoimmune response to infections. However, it is possible that elevated neuroinflammation, inducible by a diverse range of mechanisms, is important throughout the cortico-striato-thalamo-cortical circuit of OCD. Identifying brain inflammation is possible with the recent advance in positron emission tomography (PET) radioligands that bind to the translocator protein (TSPO). Translocator protein density increases when microglia are activated during neuroinflammation and the TSPO distribution volume (VT) is an index of TSPO density.

     

    OBJECTIVE:

    To determine whether TSPO VT is elevated in the dorsal caudate, orbitofrontal cortex, thalamus, ventral striatum, dorsal putamen, and anterior cingulate cortex in OCD.

     

    DESIGN, SETTING, AND PARTICIPANTS:

    This case-control study was conducted at a tertiary care psychiatric hospital from May 1, 2010, to November 30, 2016. Participants with OCD (n = 20) and age-matched healthy control individuals (n = 20) underwent a fluorine F 18-labeled N-(2-(2-fluoroethoxy)benzyl)-N-(4-phenoxypyridin-3-yl)acetamide PET scan. It is a high-quality second-generation TSPO-binding PET radiotracer. All participants were drug and medication free, nonsmoking, and otherwise healthy.

     

    MAIN OUTCOMES AND MEASURES:

    The TSPO VT was measured in the dorsal caudate, orbitofrontal cortex, thalamus, ventral striatum, dorsal putamen, and anterior cingulate cortex. Compulsions were assessed with the Yale-Brown Obsessive Compulsive Scale.

     

    RESULTS:

    In the OCD and healthy groups, the mean (SD) ages were 27.4 (7.1) years and 27.6 (6.6) years, respectively, and 11 (55%) and 8 (40%) were women, respectively. In OCD, TSPO VT was significantly elevated in these brain regions (mean, 32%; range, 31%-36% except anterior cingulate cortex, 24%; analysis of variance, effect of diagnosis: P < .001 to P = .004). Slightly lower elevations in TSPO VT (22%-29%) were present in other gray matter regions. The Yale-Brown Obsessive Compulsive Scale measure of distress associated with preventing compulsive behaviors significantly correlated with TSPO VT in the orbitofrontal cortex (uncorrected Pearson correlation r = 0.62; P = .005).


    CONCLUSIONS AND RELEVANCE:

    To our knowledge, this is the first study demonstrating inflammation within the neurocircuitry of OCD. The regional distribution of elevated TSPO VT argues that the autoimmune/neuroinflammatory theories of OCD should extend beyond the basal ganglia to include the cortico-striato-thalamo-cortical circuit. Immunomodulatory therapies should be investigated in adult OCD, rather than solely childhood OCD, particularly in cases with prominent distress when preventing compulsions.​ 

     

    Author information

    Attwells S1, Setiawan E2, Wilson AA3, Rusjan PM2, Mizrahi R4, Miler L2, Xu C2, Richter MA5, Kahn A3, Kish SJ4, Houle S3, Ravindran L6, Meyer JH4.

    Research Imaging Centre, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada2Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada.

    Research Imaging Centre, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.

    Research Imaging Centre, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada3Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.

    Research Imaging Centre, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada2Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada3Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.

    Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada4Frederick W. Thompson Anxiety Disorders Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

    Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. 

  • 덧글달기
    덧글달기
       IP : 18.221.146.223

    등록